Assenagon Asset Management’s Merck MRK Stock Holding History

Assenagon Asset Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$347M	Buy	2,702,992 +1,959,778	+264%	+$229M	0.43%	38
2026 Q1	$89.4M	Buy	743,214 +201,642	+37%	+$23.3M	0.14%	131
2025 Q4	$57M	Sell	541,572 -4,955,092	-90%	-$465M	0.08%	195
2025 Q3	$461M	Buy	5,496,664 +3,618,532	+193%	+$298M	0.63%	27
2025 Q2	$149M	Buy	1,878,132 +1,391,088	+286%	+$111M	0.22%	91
2025 Q1	$43.7M	Sell	487,044 -222,494	-31%	-$20.8M	0.07%	229
2024 Q4	$70.6M	Sell	709,538 -1,440,399	-67%	-$148M	0.11%	157
2024 Q3	$244M	Buy	2,149,937 +805,571	+60%	+$95.7M	0.45%	38
2024 Q2	$166M	Sell	1,344,366 -290,538	-18%	-$37.4M	0.37%	53
2024 Q1	$216M	Buy	1,634,904 +470,217	+40%	+$58M	0.51%	32
2023 Q4	$127M	Sell	1,164,687 -181,345	-13%	-$18.8M	0.34%	55
2023 Q3	$139M	Buy	1,346,032 +817,128	+154%	+$88.1M	0.43%	40
2023 Q2	$61M	Sell	528,904 -1,227,869	-70%	-$139M	0.21%	96
2023 Q1	$187M	Buy	1,756,773 +257,964	+17%	+$27.9M	0.66%	28
2022 Q4	$166M	Sell	1,498,809 -1,148,321	-43%	-$117M	0.6%	31
2022 Q3	$228M	Buy	2,647,130 +1,901,328	+255%	+$170M	0.88%	20
2022 Q2	$68M	Sell	745,802 -326,773	-30%	-$29M	0.25%	86
2022 Q1	$88M	Buy	1,072,575 +1,022,576	+2,045%	+$80.6M	0.24%	83
2021 Q4	$3.83M	Buy	49,999 +3,741	+8%	+$298K	0.01%	589
2021 Q3	$3.47M	Buy	46,258 +24,553	+113%	+$1.87M	0.01%	528
2021 Q2	$1.69M	Buy	21,705 +1,187	+6%	+$88.3K	0.01%	741
2021 Q1	$1.51M	Buy	20,518 +1,230	+6%	+$90.7K	0.01%	792
2020 Q4	$1.51M	Buy	19,288 +6,151	+47%	+$470K	0.01%	600
2020 Q3	$1.04M	Buy	13,137 +1,587	+14%	+$124K	0.01%	786
2020 Q2	$852K	Sell	11,550 -45,379	-80%	-$3.42M	0.01%	853
2020 Q1	$4.18M	Sell	56,929 -2,125,085	-97%	-$167M	0.03%	248
2019 Q4	$189M	Buy	2,182,014 +1,341,095	+159%	+$110M	1.19%	18
2019 Q3	$67.5M	Buy	840,919 +45,210	+6%	+$3.62M	0.45%	50
2019 Q2	$63.7M	Buy	795,709 +782,399	+5,878%	+$59.9M	0.48%	45
2019 Q1	$1.06M	Sell	13,310 -1,152	-8%	-$86.2K	0.01%	672
2018 Q4	$1.05M	Sell	14,462 -1,149,588	-99%	-$81.2M	0.01%	635
2018 Q3	$78.8M	Buy	1,164,050 +912,203	+362%	+$58.1M	0.78%	23
2018 Q2	$14.6M	Buy	+251,847	New	+$14.2M	0.17%	134
2017 Q4	–	Sell	-764,610	Closed	-$46.7M	–	736
2017 Q3	$46.7M	Buy	+764,610	New	+$46.4M	0.43%	63
2017 Q2	–	Sell	-1,228,256	Closed	-$74.5M	–	269
2017 Q1	$74.5M	Buy	+1,228,256	New	+$74.5M	1.59%	11

Other funds holding MRK

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

ORIO

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Assenagon Asset Management's MRK Position: Q2 2026 in Review

Assenagon Asset Management increased its Merck (MRK) stake by 264% in Q2 2026, buying an estimated $229M and bringing the position to 2,702,992 shares worth $347M. The position accounts for 0.43% of the portfolio, ranked #38.

Assenagon Asset Management first reported a position in MRK in Q1 2017 and has held it in 35 quarters since. The position peaked at $461M in Q3 2025. 978 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Assenagon Asset Management held 2,702,992 shares of Merck worth $347M as of Q2 2026.
Assenagon Asset Management bought 1,959,778 Merck shares in Q2 2026, an estimated $229M.
Merck made up 0.43% of Assenagon Asset Management's portfolio in Q2 2026, its #38 holding.
Assenagon Asset Management first reported a position in Merck in Q1 2017 and has held it in 35 quarters since.
Assenagon Asset Management's Merck position peaked at $461M in Q3 2025.
978 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.